Global Custom Recombinant Antibody Conversion Service Supply, Demand and Key Producers, 2023-2029
The global Custom Recombinant Antibody Conversion Service market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Custom Recombinant Antibody Conversion Service demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Custom Recombinant Antibody Conversion Service, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Custom Recombinant Antibody Conversion Service that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Custom Recombinant Antibody Conversion Service total market, 2018-2029, (USD Million)
Global Custom Recombinant Antibody Conversion Service total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Custom Recombinant Antibody Conversion Service total market, key domestic companies and share, (USD Million)
Global Custom Recombinant Antibody Conversion Service revenue by player and market share 2018-2023, (USD Million)
Global Custom Recombinant Antibody Conversion Service total market by Type, CAGR, 2018-2029, (USD Million)
Global Custom Recombinant Antibody Conversion Service total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Custom Recombinant Antibody Conversion Service market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Creative Biolabs, Abnova Corporation, GenScript Biotech Corporation, Bio-Rad Laboratories, Thermo Fisher Scientific, Covance Inc., Rockland Immunochemicals Inc., LakePharma Inc. and ProteoGenix, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Custom Recombinant Antibody Conversion Service market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Custom Recombinant Antibody Conversion Service Market, By Region:
1. How big is the global Custom Recombinant Antibody Conversion Service market?
2. What is the demand of the global Custom Recombinant Antibody Conversion Service market?
3. What is the year over year growth of the global Custom Recombinant Antibody Conversion Service market?
4. What is the total value of the global Custom Recombinant Antibody Conversion Service market?
5. Who are the major players in the global Custom Recombinant Antibody Conversion Service market?
6. What are the growth factors driving the market demand?
This report studies the global Custom Recombinant Antibody Conversion Service demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Custom Recombinant Antibody Conversion Service, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Custom Recombinant Antibody Conversion Service that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Custom Recombinant Antibody Conversion Service total market, 2018-2029, (USD Million)
Global Custom Recombinant Antibody Conversion Service total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Custom Recombinant Antibody Conversion Service total market, key domestic companies and share, (USD Million)
Global Custom Recombinant Antibody Conversion Service revenue by player and market share 2018-2023, (USD Million)
Global Custom Recombinant Antibody Conversion Service total market by Type, CAGR, 2018-2029, (USD Million)
Global Custom Recombinant Antibody Conversion Service total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Custom Recombinant Antibody Conversion Service market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Creative Biolabs, Abnova Corporation, GenScript Biotech Corporation, Bio-Rad Laboratories, Thermo Fisher Scientific, Covance Inc., Rockland Immunochemicals Inc., LakePharma Inc. and ProteoGenix, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Custom Recombinant Antibody Conversion Service market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Custom Recombinant Antibody Conversion Service Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Fab and scFv Antibody Fragment Production
- Chimeric Antibody Production
- Bispecific Antibody Production
- Antibody Labeling and Conjugation
- Research and Development
- Diagnostics
- Therapeutics
- Biomanufacturing
- Agriculture and Food
- Others
- Creative Biolabs
- Abnova Corporation
- GenScript Biotech Corporation
- Bio-Rad Laboratories
- Thermo Fisher Scientific
- Covance Inc.
- Rockland Immunochemicals Inc.
- LakePharma Inc.
- ProteoGenix
- ProMab Biotechnologies Inc.
- Sino Biological Inc.
- BOC Sciences
- Antitope Limited
- Absolute Antibody Ltd.
- Genscript USA Inc.
- OriGene Technologies Inc.
- Fitzgerald Industries International
- Novus Biologicals LLC
- BioLegend Inc.
- RayBiotech Inc.
- Proteintech Group Inc.
- ACROBiosystems
- Atlas Antibodies AB
- Agilent Technologies
- Molecular Innovations Inc.
1. How big is the global Custom Recombinant Antibody Conversion Service market?
2. What is the demand of the global Custom Recombinant Antibody Conversion Service market?
3. What is the year over year growth of the global Custom Recombinant Antibody Conversion Service market?
4. What is the total value of the global Custom Recombinant Antibody Conversion Service market?
5. Who are the major players in the global Custom Recombinant Antibody Conversion Service market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Custom Recombinant Antibody Conversion Service Introduction
1.2 World Custom Recombinant Antibody Conversion Service Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Custom Recombinant Antibody Conversion Service Total Market by Region (by Headquarter Location)
1.3.1 World Custom Recombinant Antibody Conversion Service Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Custom Recombinant Antibody Conversion Service Market Size (2018-2029)
1.3.3 China Custom Recombinant Antibody Conversion Service Market Size (2018-2029)
1.3.4 Europe Custom Recombinant Antibody Conversion Service Market Size (2018-2029)
1.3.5 Japan Custom Recombinant Antibody Conversion Service Market Size (2018-2029)
1.3.6 South Korea Custom Recombinant Antibody Conversion Service Market Size (2018-2029)
1.3.7 ASEAN Custom Recombinant Antibody Conversion Service Market Size (2018-2029)
1.3.8 India Custom Recombinant Antibody Conversion Service Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Custom Recombinant Antibody Conversion Service Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Custom Recombinant Antibody Conversion Service Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Custom Recombinant Antibody Conversion Service Consumption Value (2018-2029)
2.2 World Custom Recombinant Antibody Conversion Service Consumption Value by Region
2.2.1 World Custom Recombinant Antibody Conversion Service Consumption Value by Region (2018-2023)
2.2.2 World Custom Recombinant Antibody Conversion Service Consumption Value Forecast by Region (2024-2029)
2.3 United States Custom Recombinant Antibody Conversion Service Consumption Value (2018-2029)
2.4 China Custom Recombinant Antibody Conversion Service Consumption Value (2018-2029)
2.5 Europe Custom Recombinant Antibody Conversion Service Consumption Value (2018-2029)
2.6 Japan Custom Recombinant Antibody Conversion Service Consumption Value (2018-2029)
2.7 South Korea Custom Recombinant Antibody Conversion Service Consumption Value (2018-2029)
2.8 ASEAN Custom Recombinant Antibody Conversion Service Consumption Value (2018-2029)
2.9 India Custom Recombinant Antibody Conversion Service Consumption Value (2018-2029)
3 WORLD CUSTOM RECOMBINANT ANTIBODY CONVERSION SERVICE COMPANIES COMPETITIVE ANALYSIS
3.1 World Custom Recombinant Antibody Conversion Service Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Custom Recombinant Antibody Conversion Service Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Custom Recombinant Antibody Conversion Service in 2022
3.2.3 Global Concentration Ratios (CR8) for Custom Recombinant Antibody Conversion Service in 2022
3.3 Custom Recombinant Antibody Conversion Service Company Evaluation Quadrant
3.4 Custom Recombinant Antibody Conversion Service Market: Overall Company Footprint Analysis
3.4.1 Custom Recombinant Antibody Conversion Service Market: Region Footprint
3.4.2 Custom Recombinant Antibody Conversion Service Market: Company Product Type Footprint
3.4.3 Custom Recombinant Antibody Conversion Service Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Custom Recombinant Antibody Conversion Service Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Custom Recombinant Antibody Conversion Service Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Custom Recombinant Antibody Conversion Service Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Custom Recombinant Antibody Conversion Service Consumption Value Comparison
4.2.1 United States VS China: Custom Recombinant Antibody Conversion Service Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Custom Recombinant Antibody Conversion Service Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Custom Recombinant Antibody Conversion Service Companies and Market Share, 2018-2023
4.3.1 United States Based Custom Recombinant Antibody Conversion Service Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Custom Recombinant Antibody Conversion Service Revenue, (2018-2023)
4.4 China Based Companies Custom Recombinant Antibody Conversion Service Revenue and Market Share, 2018-2023
4.4.1 China Based Custom Recombinant Antibody Conversion Service Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Custom Recombinant Antibody Conversion Service Revenue, (2018-2023)
4.5 Rest of World Based Custom Recombinant Antibody Conversion Service Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Custom Recombinant Antibody Conversion Service Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Custom Recombinant Antibody Conversion Service Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Custom Recombinant Antibody Conversion Service Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Fab and scFv Antibody Fragment Production
5.2.2 Chimeric Antibody Production
5.2.3 Bispecific Antibody Production
5.2.4 Antibody Labeling and Conjugation
5.3 Market Segment by Type
5.3.1 World Custom Recombinant Antibody Conversion Service Market Size by Type (2018-2023)
5.3.2 World Custom Recombinant Antibody Conversion Service Market Size by Type (2024-2029)
5.3.3 World Custom Recombinant Antibody Conversion Service Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Custom Recombinant Antibody Conversion Service Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Research and Development
6.2.2 Diagnostics
6.2.3 Therapeutics
6.2.4 Biomanufacturing
6.2.5 Biomanufacturing
6.2.6 Others
6.3 Market Segment by Application
6.3.1 World Custom Recombinant Antibody Conversion Service Market Size by Application (2018-2023)
6.3.2 World Custom Recombinant Antibody Conversion Service Market Size by Application (2024-2029)
6.3.3 World Custom Recombinant Antibody Conversion Service Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Creative Biolabs
7.1.1 Creative Biolabs Details
7.1.2 Creative Biolabs Major Business
7.1.3 Creative Biolabs Custom Recombinant Antibody Conversion Service Product and Services
7.1.4 Creative Biolabs Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Creative Biolabs Recent Developments/Updates
7.1.6 Creative Biolabs Competitive Strengths & Weaknesses
7.2 Abnova Corporation
7.2.1 Abnova Corporation Details
7.2.2 Abnova Corporation Major Business
7.2.3 Abnova Corporation Custom Recombinant Antibody Conversion Service Product and Services
7.2.4 Abnova Corporation Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Abnova Corporation Recent Developments/Updates
7.2.6 Abnova Corporation Competitive Strengths & Weaknesses
7.3 GenScript Biotech Corporation
7.3.1 GenScript Biotech Corporation Details
7.3.2 GenScript Biotech Corporation Major Business
7.3.3 GenScript Biotech Corporation Custom Recombinant Antibody Conversion Service Product and Services
7.3.4 GenScript Biotech Corporation Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 GenScript Biotech Corporation Recent Developments/Updates
7.3.6 GenScript Biotech Corporation Competitive Strengths & Weaknesses
7.4 Bio-Rad Laboratories
7.4.1 Bio-Rad Laboratories Details
7.4.2 Bio-Rad Laboratories Major Business
7.4.3 Bio-Rad Laboratories Custom Recombinant Antibody Conversion Service Product and Services
7.4.4 Bio-Rad Laboratories Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Bio-Rad Laboratories Recent Developments/Updates
7.4.6 Bio-Rad Laboratories Competitive Strengths & Weaknesses
7.5 Thermo Fisher Scientific
7.5.1 Thermo Fisher Scientific Details
7.5.2 Thermo Fisher Scientific Major Business
7.5.3 Thermo Fisher Scientific Custom Recombinant Antibody Conversion Service Product and Services
7.5.4 Thermo Fisher Scientific Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Thermo Fisher Scientific Recent Developments/Updates
7.5.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.6 Covance Inc.
7.6.1 Covance Inc. Details
7.6.2 Covance Inc. Major Business
7.6.3 Covance Inc. Custom Recombinant Antibody Conversion Service Product and Services
7.6.4 Covance Inc. Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Covance Inc. Recent Developments/Updates
7.6.6 Covance Inc. Competitive Strengths & Weaknesses
7.7 Rockland Immunochemicals Inc.
7.7.1 Rockland Immunochemicals Inc. Details
7.7.2 Rockland Immunochemicals Inc. Major Business
7.7.3 Rockland Immunochemicals Inc. Custom Recombinant Antibody Conversion Service Product and Services
7.7.4 Rockland Immunochemicals Inc. Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Rockland Immunochemicals Inc. Recent Developments/Updates
7.7.6 Rockland Immunochemicals Inc. Competitive Strengths & Weaknesses
7.8 LakePharma Inc.
7.8.1 LakePharma Inc. Details
7.8.2 LakePharma Inc. Major Business
7.8.3 LakePharma Inc. Custom Recombinant Antibody Conversion Service Product and Services
7.8.4 LakePharma Inc. Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 LakePharma Inc. Recent Developments/Updates
7.8.6 LakePharma Inc. Competitive Strengths & Weaknesses
7.9 ProteoGenix
7.9.1 ProteoGenix Details
7.9.2 ProteoGenix Major Business
7.9.3 ProteoGenix Custom Recombinant Antibody Conversion Service Product and Services
7.9.4 ProteoGenix Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 ProteoGenix Recent Developments/Updates
7.9.6 ProteoGenix Competitive Strengths & Weaknesses
7.10 ProMab Biotechnologies Inc.
7.10.1 ProMab Biotechnologies Inc. Details
7.10.2 ProMab Biotechnologies Inc. Major Business
7.10.3 ProMab Biotechnologies Inc. Custom Recombinant Antibody Conversion Service Product and Services
7.10.4 ProMab Biotechnologies Inc. Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 ProMab Biotechnologies Inc. Recent Developments/Updates
7.10.6 ProMab Biotechnologies Inc. Competitive Strengths & Weaknesses
7.11 Sino Biological Inc.
7.11.1 Sino Biological Inc. Details
7.11.2 Sino Biological Inc. Major Business
7.11.3 Sino Biological Inc. Custom Recombinant Antibody Conversion Service Product and Services
7.11.4 Sino Biological Inc. Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Sino Biological Inc. Recent Developments/Updates
7.11.6 Sino Biological Inc. Competitive Strengths & Weaknesses
7.12 BOC Sciences
7.12.1 BOC Sciences Details
7.12.2 BOC Sciences Major Business
7.12.3 BOC Sciences Custom Recombinant Antibody Conversion Service Product and Services
7.12.4 BOC Sciences Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 BOC Sciences Recent Developments/Updates
7.12.6 BOC Sciences Competitive Strengths & Weaknesses
7.13 Antitope Limited
7.13.1 Antitope Limited Details
7.13.2 Antitope Limited Major Business
7.13.3 Antitope Limited Custom Recombinant Antibody Conversion Service Product and Services
7.13.4 Antitope Limited Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Antitope Limited Recent Developments/Updates
7.13.6 Antitope Limited Competitive Strengths & Weaknesses
7.14 Absolute Antibody Ltd.
7.14.1 Absolute Antibody Ltd. Details
7.14.2 Absolute Antibody Ltd. Major Business
7.14.3 Absolute Antibody Ltd. Custom Recombinant Antibody Conversion Service Product and Services
7.14.4 Absolute Antibody Ltd. Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Absolute Antibody Ltd. Recent Developments/Updates
7.14.6 Absolute Antibody Ltd. Competitive Strengths & Weaknesses
7.15 Genscript USA Inc.
7.15.1 Genscript USA Inc. Details
7.15.2 Genscript USA Inc. Major Business
7.15.3 Genscript USA Inc. Custom Recombinant Antibody Conversion Service Product and Services
7.15.4 Genscript USA Inc. Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Genscript USA Inc. Recent Developments/Updates
7.15.6 Genscript USA Inc. Competitive Strengths & Weaknesses
7.16 OriGene Technologies Inc.
7.16.1 OriGene Technologies Inc. Details
7.16.2 OriGene Technologies Inc. Major Business
7.16.3 OriGene Technologies Inc. Custom Recombinant Antibody Conversion Service Product and Services
7.16.4 OriGene Technologies Inc. Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 OriGene Technologies Inc. Recent Developments/Updates
7.16.6 OriGene Technologies Inc. Competitive Strengths & Weaknesses
7.17 Fitzgerald Industries International
7.17.1 Fitzgerald Industries International Details
7.17.2 Fitzgerald Industries International Major Business
7.17.3 Fitzgerald Industries International Custom Recombinant Antibody Conversion Service Product and Services
7.17.4 Fitzgerald Industries International Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Fitzgerald Industries International Recent Developments/Updates
7.17.6 Fitzgerald Industries International Competitive Strengths & Weaknesses
7.18 Novus Biologicals LLC
7.18.1 Novus Biologicals LLC Details
7.18.2 Novus Biologicals LLC Major Business
7.18.3 Novus Biologicals LLC Custom Recombinant Antibody Conversion Service Product and Services
7.18.4 Novus Biologicals LLC Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Novus Biologicals LLC Recent Developments/Updates
7.18.6 Novus Biologicals LLC Competitive Strengths & Weaknesses
7.19 BioLegend Inc.
7.19.1 BioLegend Inc. Details
7.19.2 BioLegend Inc. Major Business
7.19.3 BioLegend Inc. Custom Recombinant Antibody Conversion Service Product and Services
7.19.4 BioLegend Inc. Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 BioLegend Inc. Recent Developments/Updates
7.19.6 BioLegend Inc. Competitive Strengths & Weaknesses
7.20 RayBiotech Inc.
7.20.1 RayBiotech Inc. Details
7.20.2 RayBiotech Inc. Major Business
7.20.3 RayBiotech Inc. Custom Recombinant Antibody Conversion Service Product and Services
7.20.4 RayBiotech Inc. Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 RayBiotech Inc. Recent Developments/Updates
7.20.6 RayBiotech Inc. Competitive Strengths & Weaknesses
7.21 Proteintech Group Inc.
7.21.1 Proteintech Group Inc. Details
7.21.2 Proteintech Group Inc. Major Business
7.21.3 Proteintech Group Inc. Custom Recombinant Antibody Conversion Service Product and Services
7.21.4 Proteintech Group Inc. Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023)
7.21.5 Proteintech Group Inc. Recent Developments/Updates
7.21.6 Proteintech Group Inc. Competitive Strengths & Weaknesses
7.22 ACROBiosystems
7.22.1 ACROBiosystems Details
7.22.2 ACROBiosystems Major Business
7.22.3 ACROBiosystems Custom Recombinant Antibody Conversion Service Product and Services
7.22.4 ACROBiosystems Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023)
7.22.5 ACROBiosystems Recent Developments/Updates
7.22.6 ACROBiosystems Competitive Strengths & Weaknesses
7.23 Atlas Antibodies AB
7.23.1 Atlas Antibodies AB Details
7.23.2 Atlas Antibodies AB Major Business
7.23.3 Atlas Antibodies AB Custom Recombinant Antibody Conversion Service Product and Services
7.23.4 Atlas Antibodies AB Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023)
7.23.5 Atlas Antibodies AB Recent Developments/Updates
7.23.6 Atlas Antibodies AB Competitive Strengths & Weaknesses
7.24 Agilent Technologies
7.24.1 Agilent Technologies Details
7.24.2 Agilent Technologies Major Business
7.24.3 Agilent Technologies Custom Recombinant Antibody Conversion Service Product and Services
7.24.4 Agilent Technologies Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023)
7.24.5 Agilent Technologies Recent Developments/Updates
7.24.6 Agilent Technologies Competitive Strengths & Weaknesses
7.25 Molecular Innovations Inc.
7.25.1 Molecular Innovations Inc. Details
7.25.2 Molecular Innovations Inc. Major Business
7.25.3 Molecular Innovations Inc. Custom Recombinant Antibody Conversion Service Product and Services
7.25.4 Molecular Innovations Inc. Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023)
7.25.5 Molecular Innovations Inc. Recent Developments/Updates
7.25.6 Molecular Innovations Inc. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Custom Recombinant Antibody Conversion Service Industry Chain
8.2 Custom Recombinant Antibody Conversion Service Upstream Analysis
8.3 Custom Recombinant Antibody Conversion Service Midstream Analysis
8.4 Custom Recombinant Antibody Conversion Service Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Custom Recombinant Antibody Conversion Service Introduction
1.2 World Custom Recombinant Antibody Conversion Service Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Custom Recombinant Antibody Conversion Service Total Market by Region (by Headquarter Location)
1.3.1 World Custom Recombinant Antibody Conversion Service Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Custom Recombinant Antibody Conversion Service Market Size (2018-2029)
1.3.3 China Custom Recombinant Antibody Conversion Service Market Size (2018-2029)
1.3.4 Europe Custom Recombinant Antibody Conversion Service Market Size (2018-2029)
1.3.5 Japan Custom Recombinant Antibody Conversion Service Market Size (2018-2029)
1.3.6 South Korea Custom Recombinant Antibody Conversion Service Market Size (2018-2029)
1.3.7 ASEAN Custom Recombinant Antibody Conversion Service Market Size (2018-2029)
1.3.8 India Custom Recombinant Antibody Conversion Service Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Custom Recombinant Antibody Conversion Service Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Custom Recombinant Antibody Conversion Service Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Custom Recombinant Antibody Conversion Service Consumption Value (2018-2029)
2.2 World Custom Recombinant Antibody Conversion Service Consumption Value by Region
2.2.1 World Custom Recombinant Antibody Conversion Service Consumption Value by Region (2018-2023)
2.2.2 World Custom Recombinant Antibody Conversion Service Consumption Value Forecast by Region (2024-2029)
2.3 United States Custom Recombinant Antibody Conversion Service Consumption Value (2018-2029)
2.4 China Custom Recombinant Antibody Conversion Service Consumption Value (2018-2029)
2.5 Europe Custom Recombinant Antibody Conversion Service Consumption Value (2018-2029)
2.6 Japan Custom Recombinant Antibody Conversion Service Consumption Value (2018-2029)
2.7 South Korea Custom Recombinant Antibody Conversion Service Consumption Value (2018-2029)
2.8 ASEAN Custom Recombinant Antibody Conversion Service Consumption Value (2018-2029)
2.9 India Custom Recombinant Antibody Conversion Service Consumption Value (2018-2029)
3 WORLD CUSTOM RECOMBINANT ANTIBODY CONVERSION SERVICE COMPANIES COMPETITIVE ANALYSIS
3.1 World Custom Recombinant Antibody Conversion Service Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Custom Recombinant Antibody Conversion Service Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Custom Recombinant Antibody Conversion Service in 2022
3.2.3 Global Concentration Ratios (CR8) for Custom Recombinant Antibody Conversion Service in 2022
3.3 Custom Recombinant Antibody Conversion Service Company Evaluation Quadrant
3.4 Custom Recombinant Antibody Conversion Service Market: Overall Company Footprint Analysis
3.4.1 Custom Recombinant Antibody Conversion Service Market: Region Footprint
3.4.2 Custom Recombinant Antibody Conversion Service Market: Company Product Type Footprint
3.4.3 Custom Recombinant Antibody Conversion Service Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Custom Recombinant Antibody Conversion Service Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Custom Recombinant Antibody Conversion Service Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Custom Recombinant Antibody Conversion Service Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Custom Recombinant Antibody Conversion Service Consumption Value Comparison
4.2.1 United States VS China: Custom Recombinant Antibody Conversion Service Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Custom Recombinant Antibody Conversion Service Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Custom Recombinant Antibody Conversion Service Companies and Market Share, 2018-2023
4.3.1 United States Based Custom Recombinant Antibody Conversion Service Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Custom Recombinant Antibody Conversion Service Revenue, (2018-2023)
4.4 China Based Companies Custom Recombinant Antibody Conversion Service Revenue and Market Share, 2018-2023
4.4.1 China Based Custom Recombinant Antibody Conversion Service Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Custom Recombinant Antibody Conversion Service Revenue, (2018-2023)
4.5 Rest of World Based Custom Recombinant Antibody Conversion Service Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Custom Recombinant Antibody Conversion Service Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Custom Recombinant Antibody Conversion Service Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Custom Recombinant Antibody Conversion Service Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Fab and scFv Antibody Fragment Production
5.2.2 Chimeric Antibody Production
5.2.3 Bispecific Antibody Production
5.2.4 Antibody Labeling and Conjugation
5.3 Market Segment by Type
5.3.1 World Custom Recombinant Antibody Conversion Service Market Size by Type (2018-2023)
5.3.2 World Custom Recombinant Antibody Conversion Service Market Size by Type (2024-2029)
5.3.3 World Custom Recombinant Antibody Conversion Service Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Custom Recombinant Antibody Conversion Service Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Research and Development
6.2.2 Diagnostics
6.2.3 Therapeutics
6.2.4 Biomanufacturing
6.2.5 Biomanufacturing
6.2.6 Others
6.3 Market Segment by Application
6.3.1 World Custom Recombinant Antibody Conversion Service Market Size by Application (2018-2023)
6.3.2 World Custom Recombinant Antibody Conversion Service Market Size by Application (2024-2029)
6.3.3 World Custom Recombinant Antibody Conversion Service Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Creative Biolabs
7.1.1 Creative Biolabs Details
7.1.2 Creative Biolabs Major Business
7.1.3 Creative Biolabs Custom Recombinant Antibody Conversion Service Product and Services
7.1.4 Creative Biolabs Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Creative Biolabs Recent Developments/Updates
7.1.6 Creative Biolabs Competitive Strengths & Weaknesses
7.2 Abnova Corporation
7.2.1 Abnova Corporation Details
7.2.2 Abnova Corporation Major Business
7.2.3 Abnova Corporation Custom Recombinant Antibody Conversion Service Product and Services
7.2.4 Abnova Corporation Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Abnova Corporation Recent Developments/Updates
7.2.6 Abnova Corporation Competitive Strengths & Weaknesses
7.3 GenScript Biotech Corporation
7.3.1 GenScript Biotech Corporation Details
7.3.2 GenScript Biotech Corporation Major Business
7.3.3 GenScript Biotech Corporation Custom Recombinant Antibody Conversion Service Product and Services
7.3.4 GenScript Biotech Corporation Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 GenScript Biotech Corporation Recent Developments/Updates
7.3.6 GenScript Biotech Corporation Competitive Strengths & Weaknesses
7.4 Bio-Rad Laboratories
7.4.1 Bio-Rad Laboratories Details
7.4.2 Bio-Rad Laboratories Major Business
7.4.3 Bio-Rad Laboratories Custom Recombinant Antibody Conversion Service Product and Services
7.4.4 Bio-Rad Laboratories Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Bio-Rad Laboratories Recent Developments/Updates
7.4.6 Bio-Rad Laboratories Competitive Strengths & Weaknesses
7.5 Thermo Fisher Scientific
7.5.1 Thermo Fisher Scientific Details
7.5.2 Thermo Fisher Scientific Major Business
7.5.3 Thermo Fisher Scientific Custom Recombinant Antibody Conversion Service Product and Services
7.5.4 Thermo Fisher Scientific Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Thermo Fisher Scientific Recent Developments/Updates
7.5.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.6 Covance Inc.
7.6.1 Covance Inc. Details
7.6.2 Covance Inc. Major Business
7.6.3 Covance Inc. Custom Recombinant Antibody Conversion Service Product and Services
7.6.4 Covance Inc. Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Covance Inc. Recent Developments/Updates
7.6.6 Covance Inc. Competitive Strengths & Weaknesses
7.7 Rockland Immunochemicals Inc.
7.7.1 Rockland Immunochemicals Inc. Details
7.7.2 Rockland Immunochemicals Inc. Major Business
7.7.3 Rockland Immunochemicals Inc. Custom Recombinant Antibody Conversion Service Product and Services
7.7.4 Rockland Immunochemicals Inc. Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Rockland Immunochemicals Inc. Recent Developments/Updates
7.7.6 Rockland Immunochemicals Inc. Competitive Strengths & Weaknesses
7.8 LakePharma Inc.
7.8.1 LakePharma Inc. Details
7.8.2 LakePharma Inc. Major Business
7.8.3 LakePharma Inc. Custom Recombinant Antibody Conversion Service Product and Services
7.8.4 LakePharma Inc. Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 LakePharma Inc. Recent Developments/Updates
7.8.6 LakePharma Inc. Competitive Strengths & Weaknesses
7.9 ProteoGenix
7.9.1 ProteoGenix Details
7.9.2 ProteoGenix Major Business
7.9.3 ProteoGenix Custom Recombinant Antibody Conversion Service Product and Services
7.9.4 ProteoGenix Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 ProteoGenix Recent Developments/Updates
7.9.6 ProteoGenix Competitive Strengths & Weaknesses
7.10 ProMab Biotechnologies Inc.
7.10.1 ProMab Biotechnologies Inc. Details
7.10.2 ProMab Biotechnologies Inc. Major Business
7.10.3 ProMab Biotechnologies Inc. Custom Recombinant Antibody Conversion Service Product and Services
7.10.4 ProMab Biotechnologies Inc. Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 ProMab Biotechnologies Inc. Recent Developments/Updates
7.10.6 ProMab Biotechnologies Inc. Competitive Strengths & Weaknesses
7.11 Sino Biological Inc.
7.11.1 Sino Biological Inc. Details
7.11.2 Sino Biological Inc. Major Business
7.11.3 Sino Biological Inc. Custom Recombinant Antibody Conversion Service Product and Services
7.11.4 Sino Biological Inc. Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Sino Biological Inc. Recent Developments/Updates
7.11.6 Sino Biological Inc. Competitive Strengths & Weaknesses
7.12 BOC Sciences
7.12.1 BOC Sciences Details
7.12.2 BOC Sciences Major Business
7.12.3 BOC Sciences Custom Recombinant Antibody Conversion Service Product and Services
7.12.4 BOC Sciences Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 BOC Sciences Recent Developments/Updates
7.12.6 BOC Sciences Competitive Strengths & Weaknesses
7.13 Antitope Limited
7.13.1 Antitope Limited Details
7.13.2 Antitope Limited Major Business
7.13.3 Antitope Limited Custom Recombinant Antibody Conversion Service Product and Services
7.13.4 Antitope Limited Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Antitope Limited Recent Developments/Updates
7.13.6 Antitope Limited Competitive Strengths & Weaknesses
7.14 Absolute Antibody Ltd.
7.14.1 Absolute Antibody Ltd. Details
7.14.2 Absolute Antibody Ltd. Major Business
7.14.3 Absolute Antibody Ltd. Custom Recombinant Antibody Conversion Service Product and Services
7.14.4 Absolute Antibody Ltd. Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Absolute Antibody Ltd. Recent Developments/Updates
7.14.6 Absolute Antibody Ltd. Competitive Strengths & Weaknesses
7.15 Genscript USA Inc.
7.15.1 Genscript USA Inc. Details
7.15.2 Genscript USA Inc. Major Business
7.15.3 Genscript USA Inc. Custom Recombinant Antibody Conversion Service Product and Services
7.15.4 Genscript USA Inc. Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Genscript USA Inc. Recent Developments/Updates
7.15.6 Genscript USA Inc. Competitive Strengths & Weaknesses
7.16 OriGene Technologies Inc.
7.16.1 OriGene Technologies Inc. Details
7.16.2 OriGene Technologies Inc. Major Business
7.16.3 OriGene Technologies Inc. Custom Recombinant Antibody Conversion Service Product and Services
7.16.4 OriGene Technologies Inc. Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 OriGene Technologies Inc. Recent Developments/Updates
7.16.6 OriGene Technologies Inc. Competitive Strengths & Weaknesses
7.17 Fitzgerald Industries International
7.17.1 Fitzgerald Industries International Details
7.17.2 Fitzgerald Industries International Major Business
7.17.3 Fitzgerald Industries International Custom Recombinant Antibody Conversion Service Product and Services
7.17.4 Fitzgerald Industries International Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Fitzgerald Industries International Recent Developments/Updates
7.17.6 Fitzgerald Industries International Competitive Strengths & Weaknesses
7.18 Novus Biologicals LLC
7.18.1 Novus Biologicals LLC Details
7.18.2 Novus Biologicals LLC Major Business
7.18.3 Novus Biologicals LLC Custom Recombinant Antibody Conversion Service Product and Services
7.18.4 Novus Biologicals LLC Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Novus Biologicals LLC Recent Developments/Updates
7.18.6 Novus Biologicals LLC Competitive Strengths & Weaknesses
7.19 BioLegend Inc.
7.19.1 BioLegend Inc. Details
7.19.2 BioLegend Inc. Major Business
7.19.3 BioLegend Inc. Custom Recombinant Antibody Conversion Service Product and Services
7.19.4 BioLegend Inc. Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 BioLegend Inc. Recent Developments/Updates
7.19.6 BioLegend Inc. Competitive Strengths & Weaknesses
7.20 RayBiotech Inc.
7.20.1 RayBiotech Inc. Details
7.20.2 RayBiotech Inc. Major Business
7.20.3 RayBiotech Inc. Custom Recombinant Antibody Conversion Service Product and Services
7.20.4 RayBiotech Inc. Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 RayBiotech Inc. Recent Developments/Updates
7.20.6 RayBiotech Inc. Competitive Strengths & Weaknesses
7.21 Proteintech Group Inc.
7.21.1 Proteintech Group Inc. Details
7.21.2 Proteintech Group Inc. Major Business
7.21.3 Proteintech Group Inc. Custom Recombinant Antibody Conversion Service Product and Services
7.21.4 Proteintech Group Inc. Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023)
7.21.5 Proteintech Group Inc. Recent Developments/Updates
7.21.6 Proteintech Group Inc. Competitive Strengths & Weaknesses
7.22 ACROBiosystems
7.22.1 ACROBiosystems Details
7.22.2 ACROBiosystems Major Business
7.22.3 ACROBiosystems Custom Recombinant Antibody Conversion Service Product and Services
7.22.4 ACROBiosystems Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023)
7.22.5 ACROBiosystems Recent Developments/Updates
7.22.6 ACROBiosystems Competitive Strengths & Weaknesses
7.23 Atlas Antibodies AB
7.23.1 Atlas Antibodies AB Details
7.23.2 Atlas Antibodies AB Major Business
7.23.3 Atlas Antibodies AB Custom Recombinant Antibody Conversion Service Product and Services
7.23.4 Atlas Antibodies AB Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023)
7.23.5 Atlas Antibodies AB Recent Developments/Updates
7.23.6 Atlas Antibodies AB Competitive Strengths & Weaknesses
7.24 Agilent Technologies
7.24.1 Agilent Technologies Details
7.24.2 Agilent Technologies Major Business
7.24.3 Agilent Technologies Custom Recombinant Antibody Conversion Service Product and Services
7.24.4 Agilent Technologies Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023)
7.24.5 Agilent Technologies Recent Developments/Updates
7.24.6 Agilent Technologies Competitive Strengths & Weaknesses
7.25 Molecular Innovations Inc.
7.25.1 Molecular Innovations Inc. Details
7.25.2 Molecular Innovations Inc. Major Business
7.25.3 Molecular Innovations Inc. Custom Recombinant Antibody Conversion Service Product and Services
7.25.4 Molecular Innovations Inc. Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023)
7.25.5 Molecular Innovations Inc. Recent Developments/Updates
7.25.6 Molecular Innovations Inc. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Custom Recombinant Antibody Conversion Service Industry Chain
8.2 Custom Recombinant Antibody Conversion Service Upstream Analysis
8.3 Custom Recombinant Antibody Conversion Service Midstream Analysis
8.4 Custom Recombinant Antibody Conversion Service Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Custom Recombinant Antibody Conversion Service Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Custom Recombinant Antibody Conversion Service Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Custom Recombinant Antibody Conversion Service Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Custom Recombinant Antibody Conversion Service Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Custom Recombinant Antibody Conversion Service Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Custom Recombinant Antibody Conversion Service Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Custom Recombinant Antibody Conversion Service Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Custom Recombinant Antibody Conversion Service Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Custom Recombinant Antibody Conversion Service Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Custom Recombinant Antibody Conversion Service Players in 2022
Table 12. World Custom Recombinant Antibody Conversion Service Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Custom Recombinant Antibody Conversion Service Company Evaluation Quadrant
Table 14. Head Office of Key Custom Recombinant Antibody Conversion Service Player
Table 15. Custom Recombinant Antibody Conversion Service Market: Company Product Type Footprint
Table 16. Custom Recombinant Antibody Conversion Service Market: Company Product Application Footprint
Table 17. Custom Recombinant Antibody Conversion Service Mergers & Acquisitions Activity
Table 18. United States VS China Custom Recombinant Antibody Conversion Service Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Custom Recombinant Antibody Conversion Service Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Custom Recombinant Antibody Conversion Service Companies, Headquarters (States, Country)
Table 21. United States Based Companies Custom Recombinant Antibody Conversion Service Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Custom Recombinant Antibody Conversion Service Revenue Market Share (2018-2023)
Table 23. China Based Custom Recombinant Antibody Conversion Service Companies, Headquarters (Province, Country)
Table 24. China Based Companies Custom Recombinant Antibody Conversion Service Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Custom Recombinant Antibody Conversion Service Revenue Market Share (2018-2023)
Table 26. Rest of World Based Custom Recombinant Antibody Conversion Service Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Custom Recombinant Antibody Conversion Service Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Custom Recombinant Antibody Conversion Service Revenue Market Share (2018-2023)
Table 29. World Custom Recombinant Antibody Conversion Service Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Custom Recombinant Antibody Conversion Service Market Size by Type (2018-2023) & (USD Million)
Table 31. World Custom Recombinant Antibody Conversion Service Market Size by Type (2024-2029) & (USD Million)
Table 32. World Custom Recombinant Antibody Conversion Service Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Custom Recombinant Antibody Conversion Service Market Size by Application (2018-2023) & (USD Million)
Table 34. World Custom Recombinant Antibody Conversion Service Market Size by Application (2024-2029) & (USD Million)
Table 35. Creative Biolabs Basic Information, Area Served and Competitors
Table 36. Creative Biolabs Major Business
Table 37. Creative Biolabs Custom Recombinant Antibody Conversion Service Product and Services
Table 38. Creative Biolabs Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Creative Biolabs Recent Developments/Updates
Table 40. Creative Biolabs Competitive Strengths & Weaknesses
Table 41. Abnova Corporation Basic Information, Area Served and Competitors
Table 42. Abnova Corporation Major Business
Table 43. Abnova Corporation Custom Recombinant Antibody Conversion Service Product and Services
Table 44. Abnova Corporation Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Abnova Corporation Recent Developments/Updates
Table 46. Abnova Corporation Competitive Strengths & Weaknesses
Table 47. GenScript Biotech Corporation Basic Information, Area Served and Competitors
Table 48. GenScript Biotech Corporation Major Business
Table 49. GenScript Biotech Corporation Custom Recombinant Antibody Conversion Service Product and Services
Table 50. GenScript Biotech Corporation Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. GenScript Biotech Corporation Recent Developments/Updates
Table 52. GenScript Biotech Corporation Competitive Strengths & Weaknesses
Table 53. Bio-Rad Laboratories Basic Information, Area Served and Competitors
Table 54. Bio-Rad Laboratories Major Business
Table 55. Bio-Rad Laboratories Custom Recombinant Antibody Conversion Service Product and Services
Table 56. Bio-Rad Laboratories Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Bio-Rad Laboratories Recent Developments/Updates
Table 58. Bio-Rad Laboratories Competitive Strengths & Weaknesses
Table 59. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 60. Thermo Fisher Scientific Major Business
Table 61. Thermo Fisher Scientific Custom Recombinant Antibody Conversion Service Product and Services
Table 62. Thermo Fisher Scientific Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Thermo Fisher Scientific Recent Developments/Updates
Table 64. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 65. Covance Inc. Basic Information, Area Served and Competitors
Table 66. Covance Inc. Major Business
Table 67. Covance Inc. Custom Recombinant Antibody Conversion Service Product and Services
Table 68. Covance Inc. Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Covance Inc. Recent Developments/Updates
Table 70. Covance Inc. Competitive Strengths & Weaknesses
Table 71. Rockland Immunochemicals Inc. Basic Information, Area Served and Competitors
Table 72. Rockland Immunochemicals Inc. Major Business
Table 73. Rockland Immunochemicals Inc. Custom Recombinant Antibody Conversion Service Product and Services
Table 74. Rockland Immunochemicals Inc. Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Rockland Immunochemicals Inc. Recent Developments/Updates
Table 76. Rockland Immunochemicals Inc. Competitive Strengths & Weaknesses
Table 77. LakePharma Inc. Basic Information, Area Served and Competitors
Table 78. LakePharma Inc. Major Business
Table 79. LakePharma Inc. Custom Recombinant Antibody Conversion Service Product and Services
Table 80. LakePharma Inc. Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. LakePharma Inc. Recent Developments/Updates
Table 82. LakePharma Inc. Competitive Strengths & Weaknesses
Table 83. ProteoGenix Basic Information, Area Served and Competitors
Table 84. ProteoGenix Major Business
Table 85. ProteoGenix Custom Recombinant Antibody Conversion Service Product and Services
Table 86. ProteoGenix Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. ProteoGenix Recent Developments/Updates
Table 88. ProteoGenix Competitive Strengths & Weaknesses
Table 89. ProMab Biotechnologies Inc. Basic Information, Area Served and Competitors
Table 90. ProMab Biotechnologies Inc. Major Business
Table 91. ProMab Biotechnologies Inc. Custom Recombinant Antibody Conversion Service Product and Services
Table 92. ProMab Biotechnologies Inc. Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. ProMab Biotechnologies Inc. Recent Developments/Updates
Table 94. ProMab Biotechnologies Inc. Competitive Strengths & Weaknesses
Table 95. Sino Biological Inc. Basic Information, Area Served and Competitors
Table 96. Sino Biological Inc. Major Business
Table 97. Sino Biological Inc. Custom Recombinant Antibody Conversion Service Product and Services
Table 98. Sino Biological Inc. Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Sino Biological Inc. Recent Developments/Updates
Table 100. Sino Biological Inc. Competitive Strengths & Weaknesses
Table 101. BOC Sciences Basic Information, Area Served and Competitors
Table 102. BOC Sciences Major Business
Table 103. BOC Sciences Custom Recombinant Antibody Conversion Service Product and Services
Table 104. BOC Sciences Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. BOC Sciences Recent Developments/Updates
Table 106. BOC Sciences Competitive Strengths & Weaknesses
Table 107. Antitope Limited Basic Information, Area Served and Competitors
Table 108. Antitope Limited Major Business
Table 109. Antitope Limited Custom Recombinant Antibody Conversion Service Product and Services
Table 110. Antitope Limited Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Antitope Limited Recent Developments/Updates
Table 112. Antitope Limited Competitive Strengths & Weaknesses
Table 113. Absolute Antibody Ltd. Basic Information, Area Served and Competitors
Table 114. Absolute Antibody Ltd. Major Business
Table 115. Absolute Antibody Ltd. Custom Recombinant Antibody Conversion Service Product and Services
Table 116. Absolute Antibody Ltd. Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Absolute Antibody Ltd. Recent Developments/Updates
Table 118. Absolute Antibody Ltd. Competitive Strengths & Weaknesses
Table 119. Genscript USA Inc. Basic Information, Area Served and Competitors
Table 120. Genscript USA Inc. Major Business
Table 121. Genscript USA Inc. Custom Recombinant Antibody Conversion Service Product and Services
Table 122. Genscript USA Inc. Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Genscript USA Inc. Recent Developments/Updates
Table 124. Genscript USA Inc. Competitive Strengths & Weaknesses
Table 125. OriGene Technologies Inc. Basic Information, Area Served and Competitors
Table 126. OriGene Technologies Inc. Major Business
Table 127. OriGene Technologies Inc. Custom Recombinant Antibody Conversion Service Product and Services
Table 128. OriGene Technologies Inc. Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. OriGene Technologies Inc. Recent Developments/Updates
Table 130. OriGene Technologies Inc. Competitive Strengths & Weaknesses
Table 131. Fitzgerald Industries International Basic Information, Area Served and Competitors
Table 132. Fitzgerald Industries International Major Business
Table 133. Fitzgerald Industries International Custom Recombinant Antibody Conversion Service Product and Services
Table 134. Fitzgerald Industries International Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Fitzgerald Industries International Recent Developments/Updates
Table 136. Fitzgerald Industries International Competitive Strengths & Weaknesses
Table 137. Novus Biologicals LLC Basic Information, Area Served and Competitors
Table 138. Novus Biologicals LLC Major Business
Table 139. Novus Biologicals LLC Custom Recombinant Antibody Conversion Service Product and Services
Table 140. Novus Biologicals LLC Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Novus Biologicals LLC Recent Developments/Updates
Table 142. Novus Biologicals LLC Competitive Strengths & Weaknesses
Table 143. BioLegend Inc. Basic Information, Area Served and Competitors
Table 144. BioLegend Inc. Major Business
Table 145. BioLegend Inc. Custom Recombinant Antibody Conversion Service Product and Services
Table 146. BioLegend Inc. Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. BioLegend Inc. Recent Developments/Updates
Table 148. BioLegend Inc. Competitive Strengths & Weaknesses
Table 149. RayBiotech Inc. Basic Information, Area Served and Competitors
Table 150. RayBiotech Inc. Major Business
Table 151. RayBiotech Inc. Custom Recombinant Antibody Conversion Service Product and Services
Table 152. RayBiotech Inc. Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 153. RayBiotech Inc. Recent Developments/Updates
Table 154. RayBiotech Inc. Competitive Strengths & Weaknesses
Table 155. Proteintech Group Inc. Basic Information, Area Served and Competitors
Table 156. Proteintech Group Inc. Major Business
Table 157. Proteintech Group Inc. Custom Recombinant Antibody Conversion Service Product and Services
Table 158. Proteintech Group Inc. Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 159. Proteintech Group Inc. Recent Developments/Updates
Table 160. Proteintech Group Inc. Competitive Strengths & Weaknesses
Table 161. ACROBiosystems Basic Information, Area Served and Competitors
Table 162. ACROBiosystems Major Business
Table 163. ACROBiosystems Custom Recombinant Antibody Conversion Service Product and Services
Table 164. ACROBiosystems Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 165. ACROBiosystems Recent Developments/Updates
Table 166. ACROBiosystems Competitive Strengths & Weaknesses
Table 167. Atlas Antibodies AB Basic Information, Area Served and Competitors
Table 168. Atlas Antibodies AB Major Business
Table 169. Atlas Antibodies AB Custom Recombinant Antibody Conversion Service Product and Services
Table 170. Atlas Antibodies AB Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 171. Atlas Antibodies AB Recent Developments/Updates
Table 172. Atlas Antibodies AB Competitive Strengths & Weaknesses
Table 173. Agilent Technologies Basic Information, Area Served and Competitors
Table 174. Agilent Technologies Major Business
Table 175. Agilent Technologies Custom Recombinant Antibody Conversion Service Product and Services
Table 176. Agilent Technologies Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 177. Agilent Technologies Recent Developments/Updates
Table 178. Molecular Innovations Inc. Basic Information, Area Served and Competitors
Table 179. Molecular Innovations Inc. Major Business
Table 180. Molecular Innovations Inc. Custom Recombinant Antibody Conversion Service Product and Services
Table 181. Molecular Innovations Inc. Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 182. Global Key Players of Custom Recombinant Antibody Conversion Service Upstream (Raw Materials)
Table 183. Custom Recombinant Antibody Conversion Service Typical Customers
Table 1. World Custom Recombinant Antibody Conversion Service Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Custom Recombinant Antibody Conversion Service Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Custom Recombinant Antibody Conversion Service Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Custom Recombinant Antibody Conversion Service Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Custom Recombinant Antibody Conversion Service Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Custom Recombinant Antibody Conversion Service Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Custom Recombinant Antibody Conversion Service Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Custom Recombinant Antibody Conversion Service Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Custom Recombinant Antibody Conversion Service Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Custom Recombinant Antibody Conversion Service Players in 2022
Table 12. World Custom Recombinant Antibody Conversion Service Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Custom Recombinant Antibody Conversion Service Company Evaluation Quadrant
Table 14. Head Office of Key Custom Recombinant Antibody Conversion Service Player
Table 15. Custom Recombinant Antibody Conversion Service Market: Company Product Type Footprint
Table 16. Custom Recombinant Antibody Conversion Service Market: Company Product Application Footprint
Table 17. Custom Recombinant Antibody Conversion Service Mergers & Acquisitions Activity
Table 18. United States VS China Custom Recombinant Antibody Conversion Service Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Custom Recombinant Antibody Conversion Service Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Custom Recombinant Antibody Conversion Service Companies, Headquarters (States, Country)
Table 21. United States Based Companies Custom Recombinant Antibody Conversion Service Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Custom Recombinant Antibody Conversion Service Revenue Market Share (2018-2023)
Table 23. China Based Custom Recombinant Antibody Conversion Service Companies, Headquarters (Province, Country)
Table 24. China Based Companies Custom Recombinant Antibody Conversion Service Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Custom Recombinant Antibody Conversion Service Revenue Market Share (2018-2023)
Table 26. Rest of World Based Custom Recombinant Antibody Conversion Service Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Custom Recombinant Antibody Conversion Service Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Custom Recombinant Antibody Conversion Service Revenue Market Share (2018-2023)
Table 29. World Custom Recombinant Antibody Conversion Service Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Custom Recombinant Antibody Conversion Service Market Size by Type (2018-2023) & (USD Million)
Table 31. World Custom Recombinant Antibody Conversion Service Market Size by Type (2024-2029) & (USD Million)
Table 32. World Custom Recombinant Antibody Conversion Service Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Custom Recombinant Antibody Conversion Service Market Size by Application (2018-2023) & (USD Million)
Table 34. World Custom Recombinant Antibody Conversion Service Market Size by Application (2024-2029) & (USD Million)
Table 35. Creative Biolabs Basic Information, Area Served and Competitors
Table 36. Creative Biolabs Major Business
Table 37. Creative Biolabs Custom Recombinant Antibody Conversion Service Product and Services
Table 38. Creative Biolabs Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Creative Biolabs Recent Developments/Updates
Table 40. Creative Biolabs Competitive Strengths & Weaknesses
Table 41. Abnova Corporation Basic Information, Area Served and Competitors
Table 42. Abnova Corporation Major Business
Table 43. Abnova Corporation Custom Recombinant Antibody Conversion Service Product and Services
Table 44. Abnova Corporation Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Abnova Corporation Recent Developments/Updates
Table 46. Abnova Corporation Competitive Strengths & Weaknesses
Table 47. GenScript Biotech Corporation Basic Information, Area Served and Competitors
Table 48. GenScript Biotech Corporation Major Business
Table 49. GenScript Biotech Corporation Custom Recombinant Antibody Conversion Service Product and Services
Table 50. GenScript Biotech Corporation Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. GenScript Biotech Corporation Recent Developments/Updates
Table 52. GenScript Biotech Corporation Competitive Strengths & Weaknesses
Table 53. Bio-Rad Laboratories Basic Information, Area Served and Competitors
Table 54. Bio-Rad Laboratories Major Business
Table 55. Bio-Rad Laboratories Custom Recombinant Antibody Conversion Service Product and Services
Table 56. Bio-Rad Laboratories Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Bio-Rad Laboratories Recent Developments/Updates
Table 58. Bio-Rad Laboratories Competitive Strengths & Weaknesses
Table 59. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 60. Thermo Fisher Scientific Major Business
Table 61. Thermo Fisher Scientific Custom Recombinant Antibody Conversion Service Product and Services
Table 62. Thermo Fisher Scientific Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Thermo Fisher Scientific Recent Developments/Updates
Table 64. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 65. Covance Inc. Basic Information, Area Served and Competitors
Table 66. Covance Inc. Major Business
Table 67. Covance Inc. Custom Recombinant Antibody Conversion Service Product and Services
Table 68. Covance Inc. Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Covance Inc. Recent Developments/Updates
Table 70. Covance Inc. Competitive Strengths & Weaknesses
Table 71. Rockland Immunochemicals Inc. Basic Information, Area Served and Competitors
Table 72. Rockland Immunochemicals Inc. Major Business
Table 73. Rockland Immunochemicals Inc. Custom Recombinant Antibody Conversion Service Product and Services
Table 74. Rockland Immunochemicals Inc. Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Rockland Immunochemicals Inc. Recent Developments/Updates
Table 76. Rockland Immunochemicals Inc. Competitive Strengths & Weaknesses
Table 77. LakePharma Inc. Basic Information, Area Served and Competitors
Table 78. LakePharma Inc. Major Business
Table 79. LakePharma Inc. Custom Recombinant Antibody Conversion Service Product and Services
Table 80. LakePharma Inc. Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. LakePharma Inc. Recent Developments/Updates
Table 82. LakePharma Inc. Competitive Strengths & Weaknesses
Table 83. ProteoGenix Basic Information, Area Served and Competitors
Table 84. ProteoGenix Major Business
Table 85. ProteoGenix Custom Recombinant Antibody Conversion Service Product and Services
Table 86. ProteoGenix Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. ProteoGenix Recent Developments/Updates
Table 88. ProteoGenix Competitive Strengths & Weaknesses
Table 89. ProMab Biotechnologies Inc. Basic Information, Area Served and Competitors
Table 90. ProMab Biotechnologies Inc. Major Business
Table 91. ProMab Biotechnologies Inc. Custom Recombinant Antibody Conversion Service Product and Services
Table 92. ProMab Biotechnologies Inc. Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. ProMab Biotechnologies Inc. Recent Developments/Updates
Table 94. ProMab Biotechnologies Inc. Competitive Strengths & Weaknesses
Table 95. Sino Biological Inc. Basic Information, Area Served and Competitors
Table 96. Sino Biological Inc. Major Business
Table 97. Sino Biological Inc. Custom Recombinant Antibody Conversion Service Product and Services
Table 98. Sino Biological Inc. Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Sino Biological Inc. Recent Developments/Updates
Table 100. Sino Biological Inc. Competitive Strengths & Weaknesses
Table 101. BOC Sciences Basic Information, Area Served and Competitors
Table 102. BOC Sciences Major Business
Table 103. BOC Sciences Custom Recombinant Antibody Conversion Service Product and Services
Table 104. BOC Sciences Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. BOC Sciences Recent Developments/Updates
Table 106. BOC Sciences Competitive Strengths & Weaknesses
Table 107. Antitope Limited Basic Information, Area Served and Competitors
Table 108. Antitope Limited Major Business
Table 109. Antitope Limited Custom Recombinant Antibody Conversion Service Product and Services
Table 110. Antitope Limited Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Antitope Limited Recent Developments/Updates
Table 112. Antitope Limited Competitive Strengths & Weaknesses
Table 113. Absolute Antibody Ltd. Basic Information, Area Served and Competitors
Table 114. Absolute Antibody Ltd. Major Business
Table 115. Absolute Antibody Ltd. Custom Recombinant Antibody Conversion Service Product and Services
Table 116. Absolute Antibody Ltd. Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Absolute Antibody Ltd. Recent Developments/Updates
Table 118. Absolute Antibody Ltd. Competitive Strengths & Weaknesses
Table 119. Genscript USA Inc. Basic Information, Area Served and Competitors
Table 120. Genscript USA Inc. Major Business
Table 121. Genscript USA Inc. Custom Recombinant Antibody Conversion Service Product and Services
Table 122. Genscript USA Inc. Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Genscript USA Inc. Recent Developments/Updates
Table 124. Genscript USA Inc. Competitive Strengths & Weaknesses
Table 125. OriGene Technologies Inc. Basic Information, Area Served and Competitors
Table 126. OriGene Technologies Inc. Major Business
Table 127. OriGene Technologies Inc. Custom Recombinant Antibody Conversion Service Product and Services
Table 128. OriGene Technologies Inc. Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. OriGene Technologies Inc. Recent Developments/Updates
Table 130. OriGene Technologies Inc. Competitive Strengths & Weaknesses
Table 131. Fitzgerald Industries International Basic Information, Area Served and Competitors
Table 132. Fitzgerald Industries International Major Business
Table 133. Fitzgerald Industries International Custom Recombinant Antibody Conversion Service Product and Services
Table 134. Fitzgerald Industries International Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Fitzgerald Industries International Recent Developments/Updates
Table 136. Fitzgerald Industries International Competitive Strengths & Weaknesses
Table 137. Novus Biologicals LLC Basic Information, Area Served and Competitors
Table 138. Novus Biologicals LLC Major Business
Table 139. Novus Biologicals LLC Custom Recombinant Antibody Conversion Service Product and Services
Table 140. Novus Biologicals LLC Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Novus Biologicals LLC Recent Developments/Updates
Table 142. Novus Biologicals LLC Competitive Strengths & Weaknesses
Table 143. BioLegend Inc. Basic Information, Area Served and Competitors
Table 144. BioLegend Inc. Major Business
Table 145. BioLegend Inc. Custom Recombinant Antibody Conversion Service Product and Services
Table 146. BioLegend Inc. Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. BioLegend Inc. Recent Developments/Updates
Table 148. BioLegend Inc. Competitive Strengths & Weaknesses
Table 149. RayBiotech Inc. Basic Information, Area Served and Competitors
Table 150. RayBiotech Inc. Major Business
Table 151. RayBiotech Inc. Custom Recombinant Antibody Conversion Service Product and Services
Table 152. RayBiotech Inc. Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 153. RayBiotech Inc. Recent Developments/Updates
Table 154. RayBiotech Inc. Competitive Strengths & Weaknesses
Table 155. Proteintech Group Inc. Basic Information, Area Served and Competitors
Table 156. Proteintech Group Inc. Major Business
Table 157. Proteintech Group Inc. Custom Recombinant Antibody Conversion Service Product and Services
Table 158. Proteintech Group Inc. Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 159. Proteintech Group Inc. Recent Developments/Updates
Table 160. Proteintech Group Inc. Competitive Strengths & Weaknesses
Table 161. ACROBiosystems Basic Information, Area Served and Competitors
Table 162. ACROBiosystems Major Business
Table 163. ACROBiosystems Custom Recombinant Antibody Conversion Service Product and Services
Table 164. ACROBiosystems Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 165. ACROBiosystems Recent Developments/Updates
Table 166. ACROBiosystems Competitive Strengths & Weaknesses
Table 167. Atlas Antibodies AB Basic Information, Area Served and Competitors
Table 168. Atlas Antibodies AB Major Business
Table 169. Atlas Antibodies AB Custom Recombinant Antibody Conversion Service Product and Services
Table 170. Atlas Antibodies AB Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 171. Atlas Antibodies AB Recent Developments/Updates
Table 172. Atlas Antibodies AB Competitive Strengths & Weaknesses
Table 173. Agilent Technologies Basic Information, Area Served and Competitors
Table 174. Agilent Technologies Major Business
Table 175. Agilent Technologies Custom Recombinant Antibody Conversion Service Product and Services
Table 176. Agilent Technologies Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 177. Agilent Technologies Recent Developments/Updates
Table 178. Molecular Innovations Inc. Basic Information, Area Served and Competitors
Table 179. Molecular Innovations Inc. Major Business
Table 180. Molecular Innovations Inc. Custom Recombinant Antibody Conversion Service Product and Services
Table 181. Molecular Innovations Inc. Custom Recombinant Antibody Conversion Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 182. Global Key Players of Custom Recombinant Antibody Conversion Service Upstream (Raw Materials)
Table 183. Custom Recombinant Antibody Conversion Service Typical Customers
LIST OF FIGURES
Figure 1. Custom Recombinant Antibody Conversion Service Picture
Figure 2. World Custom Recombinant Antibody Conversion Service Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Custom Recombinant Antibody Conversion Service Total Market Size (2018-2029) & (USD Million)
Figure 4. World Custom Recombinant Antibody Conversion Service Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Custom Recombinant Antibody Conversion Service Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Custom Recombinant Antibody Conversion Service Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Custom Recombinant Antibody Conversion Service Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Custom Recombinant Antibody Conversion Service Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Custom Recombinant Antibody Conversion Service Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Custom Recombinant Antibody Conversion Service Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Custom Recombinant Antibody Conversion Service Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Custom Recombinant Antibody Conversion Service Revenue (2018-2029) & (USD Million)
Figure 13. Custom Recombinant Antibody Conversion Service Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Custom Recombinant Antibody Conversion Service Consumption Value (2018-2029) & (USD Million)
Figure 16. World Custom Recombinant Antibody Conversion Service Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Custom Recombinant Antibody Conversion Service Consumption Value (2018-2029) & (USD Million)
Figure 18. China Custom Recombinant Antibody Conversion Service Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Custom Recombinant Antibody Conversion Service Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Custom Recombinant Antibody Conversion Service Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Custom Recombinant Antibody Conversion Service Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Custom Recombinant Antibody Conversion Service Consumption Value (2018-2029) & (USD Million)
Figure 23. India Custom Recombinant Antibody Conversion Service Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Custom Recombinant Antibody Conversion Service by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Custom Recombinant Antibody Conversion Service Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Custom Recombinant Antibody Conversion Service Markets in 2022
Figure 27. United States VS China: Custom Recombinant Antibody Conversion Service Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Custom Recombinant Antibody Conversion Service Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Custom Recombinant Antibody Conversion Service Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Custom Recombinant Antibody Conversion Service Market Size Market Share by Type in 2022
Figure 31. Fab and scFv Antibody Fragment Production
Figure 32. Chimeric Antibody Production
Figure 33. Bispecific Antibody Production
Figure 34. Antibody Labeling and Conjugation
Figure 35. World Custom Recombinant Antibody Conversion Service Market Size Market Share by Type (2018-2029)
Figure 36. World Custom Recombinant Antibody Conversion Service Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Custom Recombinant Antibody Conversion Service Market Size Market Share by Application in 2022
Figure 38. Research and Development
Figure 39. Diagnostics
Figure 40. Therapeutics
Figure 41. Biomanufacturing
Figure 42. Agriculture and Food
Figure 43. Others
Figure 44. Custom Recombinant Antibody Conversion Service Industrial Chain
Figure 45. Methodology
Figure 46. Research Process and Data Source
Figure 1. Custom Recombinant Antibody Conversion Service Picture
Figure 2. World Custom Recombinant Antibody Conversion Service Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Custom Recombinant Antibody Conversion Service Total Market Size (2018-2029) & (USD Million)
Figure 4. World Custom Recombinant Antibody Conversion Service Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Custom Recombinant Antibody Conversion Service Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Custom Recombinant Antibody Conversion Service Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Custom Recombinant Antibody Conversion Service Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Custom Recombinant Antibody Conversion Service Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Custom Recombinant Antibody Conversion Service Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Custom Recombinant Antibody Conversion Service Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Custom Recombinant Antibody Conversion Service Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Custom Recombinant Antibody Conversion Service Revenue (2018-2029) & (USD Million)
Figure 13. Custom Recombinant Antibody Conversion Service Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Custom Recombinant Antibody Conversion Service Consumption Value (2018-2029) & (USD Million)
Figure 16. World Custom Recombinant Antibody Conversion Service Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Custom Recombinant Antibody Conversion Service Consumption Value (2018-2029) & (USD Million)
Figure 18. China Custom Recombinant Antibody Conversion Service Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Custom Recombinant Antibody Conversion Service Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Custom Recombinant Antibody Conversion Service Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Custom Recombinant Antibody Conversion Service Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Custom Recombinant Antibody Conversion Service Consumption Value (2018-2029) & (USD Million)
Figure 23. India Custom Recombinant Antibody Conversion Service Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Custom Recombinant Antibody Conversion Service by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Custom Recombinant Antibody Conversion Service Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Custom Recombinant Antibody Conversion Service Markets in 2022
Figure 27. United States VS China: Custom Recombinant Antibody Conversion Service Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Custom Recombinant Antibody Conversion Service Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Custom Recombinant Antibody Conversion Service Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Custom Recombinant Antibody Conversion Service Market Size Market Share by Type in 2022
Figure 31. Fab and scFv Antibody Fragment Production
Figure 32. Chimeric Antibody Production
Figure 33. Bispecific Antibody Production
Figure 34. Antibody Labeling and Conjugation
Figure 35. World Custom Recombinant Antibody Conversion Service Market Size Market Share by Type (2018-2029)
Figure 36. World Custom Recombinant Antibody Conversion Service Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Custom Recombinant Antibody Conversion Service Market Size Market Share by Application in 2022
Figure 38. Research and Development
Figure 39. Diagnostics
Figure 40. Therapeutics
Figure 41. Biomanufacturing
Figure 42. Agriculture and Food
Figure 43. Others
Figure 44. Custom Recombinant Antibody Conversion Service Industrial Chain
Figure 45. Methodology
Figure 46. Research Process and Data Source
